NanoSphere Health Sciences Inc.
NSHSF
$0.0038
-$0.0362-90.50%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -35.72% | -25.38% | -21.50% | -16.45% | 19.35% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -33.17% | -21.51% | -20.83% | -16.29% | 14.74% |
| Operating Income | 33.17% | 21.51% | 20.83% | 16.29% | -14.74% |
| Income Before Tax | 25.41% | 23.69% | 18.65% | 18.99% | -38,014.29% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 25.41% | 23.69% | 18.65% | 18.99% | -38,014.29% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 25.41% | 23.69% | 18.65% | 18.99% | -38,014.29% |
| EBIT | 33.17% | 21.51% | 20.83% | 16.29% | -14.74% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 25.48% | 24.11% | 18.99% | 19.34% | -25,800.00% |
| Normalized Basic EPS | 26.38% | 24.53% | 19.14% | 19.19% | 2.98% |
| EPS Diluted | 25.48% | 24.11% | 18.99% | 19.34% | -25,800.00% |
| Normalized Diluted EPS | 26.38% | 24.53% | 19.14% | 19.19% | 2.98% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | -0.09% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | -0.09% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
